Read about our latest initiatives, program updates, and important announcements in the fight against HIV/AIDS in Zimbabwe.
AFRICAN Health Ministers have committed to adopting a unified continental position aimed at accelerating efforts to end HIV and AIDS as a public health threat by 2030, amid growing concerns over global funding uncertainties and the future sustainability of HIV programmes.
Read More
The United States has launched lenacapavir (LEN), the new long-acting HIV prevention drug, in Zimbabwe, with plans to support thousands op poeple.
Read More
Zimbabwe has taken a decisive step forward in strengthening its national health system with the official commissioning of Nucleic Acid Testing (NAT) for blood screening at the National Blood Service Zimbabwe (NBSZ) headquarters in Harare.
Read More
Zimbabwe's health authorities on Thursday (19 February) began administering the long-acting injectable HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African nation seeks to curb new infections. Health Minister Douglas Mombeshora said the programme, funded by the US and the Global Fund, would initially target more than 46,000 people at high risk of contracting HIV across 24 sites nationwide.
Read More
As the African Vaccination Week (24-30 April 2025) unfolds, the First Lady of Zimbabwe, H.E. Dr. Auxillia Mnangagwa, has issued a powerful call to action. Her message is clear: no one and no area should be left behind in the quest for universal vaccination coverage.
Read More
ON Monday, the world commemorated World Aids Day 2025 under the theme "Overcoming Disruption, Transforming the Aids Response".
Read More